{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:06:56Z","timestamp":1787022416535,"version":"build-2736575974"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1507\/endocrj.ej16-0249","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T18:07:01Z","timestamp":1473271621000},"page":"1107-1112","source":"Crossref","is-referenced-by-count":31,"title":["Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome"],"prefix":"10.1507","volume":"63","author":[{"given":"Agnieszka","family":"Adamska","sequence":"first","affiliation":[{"name":"Department of the Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok 15-089, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Karczewska-Kupczewska","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases, Medical University of Bialystok, Bialystok 15-089, Poland"},{"name":"Department of Prophylaxis of Metabolic Diseases, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn 10-748, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Lebkowska","sequence":"additional","affiliation":[{"name":"Department of the Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok 15-089, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Milewski","sequence":"additional","affiliation":[{"name":"Department of Statistics and Medical Informatics, Medical University of Bialystok, Bialystok 15-089, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"G&oacute;rska","sequence":"additional","affiliation":[{"name":"Department of the Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok 15-089, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Otziomek","sequence":"additional","affiliation":[{"name":"Department of Prophylaxis of Metabolic Diseases, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn 10-748, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Nikolajuk","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases, Medical University of Bialystok, Bialystok 15-089, Poland"},{"name":"Department of Prophylaxis of Metabolic Diseases, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn 10-748, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomir","family":"Wolczynski","sequence":"additional","affiliation":[{"name":"Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Bialystok 15-089, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kowalska","sequence":"additional","affiliation":[{"name":"Department of the Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok 15-089, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bostr&ouml;m P, Wu J, Jedrychowski MP, Korde A, Ye L, <i>et al<\/i>. (2012) A PGC1-&alpha;-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. <i>Nature<\/i> 481: 463-468.","DOI":"10.1038\/nature10777"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, <i>et al<\/i>. (2013) FNDC5\/irisin is not only a myokine but also an adipokine. <i>PLoS One<\/i> 8: e60563.","DOI":"10.1371\/journal.pone.0060563"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, <i>et al<\/i>. (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. <i>J Clin Endocrinol Metab<\/i> 98: E769-778.","DOI":"10.1210\/jc.2012-2749"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zhang Y, Li R, Meng Y, Li S, Donelan W, <i>et al<\/i>. (2014) Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. <i>Diabetes<\/i> 63: 514-525.","DOI":"10.2337\/db13-1106"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lee HJ, Lee JO, Kim N, Kim JK, Kim HI, <i>et al<\/i>. (2015) Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. <i>Mol Endocrinol<\/i> 6: 873-881.","DOI":"10.1210\/me.2014-1353"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Xiong XQ, Chen D, Sun HJ, Ding L, Wang JJ, <i>et al<\/i>. (2015) FNDC5 overexpression and irisin ameliorate glucose\/lipid metabolic derangements and enhance lipolysis in obesity. <i>Biochim Biophys Acta<\/i> 1852: 1867-1875.","DOI":"10.1016\/j.bbadis.2015.06.017"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, <i>et al<\/i>. (2013) Circulating irisin in relation to insulin resistance and the metabolic syndrome. <i>J Clin Endocrinol Metab<\/i> 98: 4899-4907.","DOI":"10.1210\/jc.2013-2373"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, <i>et al<\/i>. (2013) Serum irisin levels in new-onset type 2 diabetes. <i>Diabetes Res Clin Pract<\/i> 100: 96-101.","DOI":"10.1016\/j.diabres.2013.01.007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Staiger H, B&ouml;hm A, Scheler M, Berti L, Machann J, <i>et al<\/i>. (2013) Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived &lsquo;browning&rsquo; factor irisin, determines insulin sensitivity. <i>PLoS One<\/i> 8: e61903.","DOI":"10.1371\/journal.pone.0061903"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Al-Daghri NM, Alokail MS, Rahman S, Amer OE, Al-Attas OS, <i>et al<\/i>. (2015) Habitual physical activity is associated with circulating irisin in healthy controls but not in subjects with diabetes mellitus type 2. <i>Eur J Clin Invest <\/i>8: 775-781.","DOI":"10.1111\/eci.12468"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kuzmicki M, Telejko B, Lipinska D, Pliszka J, Szamatowicz M, <i>et al<\/i>. (2014) Serum irisin concentration in women with gestational diabetes. <i>Gynecol Endocrinol<\/i> 30: 636-639.","DOI":"10.3109\/09513590.2014.920006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. <i>Endocr Rev<\/i> 33: 981-1030.","DOI":"10.1210\/er.2011-1034"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Li M, Yang M, Zhou X, Fang X, Hu W, <i>et al<\/i>. (2015) Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome. <i>J Clin Endocrinol Metab<\/i> 100: 1485-1493.","DOI":"10.1210\/jc.2014-2544"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chang CL, Huang SY, Soong YK, Cheng PJ, Wang CJ, <i>et al<\/i>. (2014) Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome. <i>J Clin Endocrinol Metab<\/i> 99: E2539-2548.","DOI":"10.1210\/jc.2014-1180"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kowalska I, Adamska A, Malecki MT, Karczewska-Kupczewska M, Nikolajuk A, <i>et al<\/i>. (2012) Impact of the FTO gene variation on fat oxidation and its potential influence on body weight in women with polycystic ovary syndrome. <i>Clin Endocrinol (Oxf)<\/i> 77: 120-125.","DOI":"10.1111\/j.1365-2265.2012.04379.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. <i>Fertil Steril<\/i> 81: 19-25.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. <i>Am J Physiol<\/i> 237: E214-223.","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. <i>J Clin Endocrinol Metab<\/i> 84: 3666-3672.","DOI":"10.1210\/jcem.84.10.6079"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Duncombe WG (1964) The colorimetric micro-determination of non-esterified fatty acids in plasma. <i>Clin Chim Acta<\/i> 9: 122-125.","DOI":"10.1016\/0009-8981(64)90004-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Polyzos SA, Kountouras J, Shields K, Mantzoros CS (2013) Irisin: a renaissance in metabolism? <i>Metabolism<\/i> 62: 1037-1044.","DOI":"10.1016\/j.metabol.2013.04.008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Frederich RC, Hamann A, Anderson S, L&ouml;llmann B, Lowell BB, <i>et al<\/i>. (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. <i>Nat Med<\/i> 1: 1311-1314.","DOI":"10.1038\/nm1295-1311"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, <i>et al<\/i>. (2013) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. <i>Peptides<\/i> 39: 125-130.","DOI":"10.1016\/j.peptides.2012.11.014"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. de la Iglesia R, Lopez-Legarrea P, Crujeiras AB, Pardo M, Casanueva FF, <i>et al<\/i>. (2014) Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. <i>Clin Endocrinol (Oxf)<\/i> 81: 306-311.","DOI":"10.1111\/cen.12383"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Crujeiras AB, Pardo M, Casanueva FF (2015) Irisin: &lsquo;fat&rsquo; or artefact. <i>Clin Endocrinol (Oxf)<\/i> 82: 467-474.","DOI":"10.1111\/cen.12627"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/12\/63_EJ16-0249\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T03:47:38Z","timestamp":1568346458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/12\/63_EJ16-0249\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0249","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}